AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient
Prospective, multicenter FDA IDE study found an IRE-based treatment strategy was associated with longer overall survival in Stage III pancreatic cancer; new Category I CPT code for open pancreatic IRE takes effect
Policy Applies Medical Necessity Criteria Across Medicare Administrative Contractor (MAC) Jurisdictions for Eligible Prostate and Liver Cancer Patients
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative
Delivered its eighth consecutive quarter of double-digit Med Tech segment growth and positive adjusted EBITDA
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on
Medical Technology Executive Brings More than 20 years of Leadership Experience, Including Cardiovascular, Endovascular and Oncology Markets, with a Track Record of Accelerating Growth and Improving Profitability
Jim
Investigator-Led Study Will Evaluate Imaging Biomarkers That May Help Predict Thrombectomy Success and Inform Long-Term PE Care
AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring
AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient
Delivered its seventh consecutive quarter of double-digit Med Tech segment growth and positive adjusted EBITDA
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on
AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today
Prospective Feasibility Study to Examine IRE as a Tissue-Sparing, Minimally Invasive Option for Men with BPH-Related Lower Urinary Tract Symptoms
AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused
Palmetto GBA Medicare Coverage Effective July 5, 2026 Advances NanoKnife IRE Reimbursement Access in Prostate and Liver Cancer, Building on Category I CPT Codes Toward Broader National Payer Coverage
AngioDynamics,
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient
Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 months
Results Presented at AUA 2026
AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood
